Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
CasInvent Pharma logo — Novel Treatment of Leukemias, Lymphomas and Solid Tumors wit...

CasInvent Pharma

Novel Treatment of Leukemias, Lymphomas and Solid Tumors with Highly Potent and Selective Inhibitors of CK1 Kinases

Founded 2020 Czech Republic Czech Republic 6 employees Seed Total: $2.90M Pharmaceutical

General Information

Company Name CasInvent Pharma
Founded Year 2020
Location Czech Republic Czech Republic +1
Employees 6
Industries Pharmaceutical
Funding Stage Seed
Social

Get notified when CasInvent Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CasInvent Pharma

CasInvent Pharma is a pharmaceutical startup with a mission to introduce innovative therapeutic options for selected leukemias to the market. The company's primary focus lies in the development of highly selective small molecule inhibitors of casein kinase I (CK1), with a key development program aimed at identifying new drugs for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). Established as a spin-off company of Masaryk University in cooperation with the investment partner i&i Prague in 2020, CasInvent Pharma is based in the Czech Republic. The company secured a significant €1.60M Seed Round investment on 31 January 2024 from a group of investors including i&I Bio, KHAN Technology Transfer Fund, i&i Prague, BIOINVESTIMED as, and the Holeček Family Foundation. CasInvent Pharma's slogan, "Novel Treatment of Leukemias, Lymphomas and Solid Tumors with Highly Potent and Selective Inhibitors of CK1 Kinases," encapsulates its commitment to pioneering treatment in the field of oncology.

Taxonomy: pharmaceuticals, leukemia treatment, oncology, small molecule inhibitors, drug development, investor partnership, Masaryk University, i&i Prague, spin-off company, CK1 kinase inhibitors, acute myeloid leukemia, chronic lymphocytic leukemia, proprietary drug development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 5
Investor Investor
•••• •••• 		31 Jan 2024
Seed Round •••••• 2
Investor
•••• •••• 		26 Sep 2022

CasInvent Pharma Alternatives & Competitors

CasInvent Pharma vs
Moleculin Biotech, Inc.
Moleculin Biotech, Inc. United States

Groundbreaking Cancer Therapies

Post Ipo Equity
22 employees
Biotechnology, Pharmaceutical
CasInvent Pharma vs
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. United States

VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases

Series C
3 employees
Biopharma, Biotechnology
CasInvent Pharma vs
Oryzon Genomics SA
Oryzon Genomics SA Spain

Pioneering personalized medicine in epigenetics

IPO
60 employees

FAQ About CasInvent Pharma

Novel Treatment of Leukemias, Lymphomas and Solid Tumors with Highly Potent and Selective Inhibitors of CK1 Kinases
CasInvent Pharma was founded in 2020.
CasInvent Pharma is headquartered in Czech Republic.
CasInvent Pharma operates in the following industries: Pharmaceutical.
CasInvent Pharma has approximately 6 employees.
CasInvent Pharma has completed 2 funding rounds, raising a total of $2.90M. The latest funding stage is Seed.
Top alternatives and competitors to CasInvent Pharma include Moleculin Biotech, Inc., Cleave Therapeutics, Inc., Oryzon Genomics SA, OneChain Immunotherapeutics, Ascentage Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CasInvent Pharma and Moleculin Biotech, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CasInvent Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy